Management of Aortic Stenosis: 2021 ESC/EACTS Guidelines

Written By :  MD Editorial Team
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2021-12-18 06:00 GMT   |   Update On 2021-12-18 06:58 GMT
Advertisement

Aortic stenosis is the most common and serious valve disease problem. Aortic stenosis is a narrowing of the aortic valve opening. Although some people have aortic stenosis because of a congenital heart defect of bicuspid aortic valve, this condition more commonly develops as aging progresses calcifications or scarring damages the valve and restricts the amount of blood flowing through. The aortic valve sclerosis seem to affect abouts one fourth of adults over 65 years of age, while the aortic valve stenosis is present in 2–9% of general population over 65 years of age.

Advertisement

The recent 2021 ESC/EACTS Guidelines for the management of valvular heart disease enlisted guidelines of management various valvular diseases. Aortic stenosis is of atmost concern due to its rising prevalence in older population. They enumerated diagnostic and intervention techniques in both symptomatic and asymptomatic aortic stenosis.

The guidelines are published in European Heart Journal.

The guidelines signified the following points

• Echocardiography is key to confirm the diagnosis and severity of aortic stenosis, assessing valve calcification, Left Ventricular (LV) function and wall thickness, detecting other valve disease or aortic pathology. Current international recommendations for the echocardiographic evaluation of patients with aortic stenosis depend upon measurement of mean pressure gradient.

• High-gradient aortic stenosis [mean gradient ≥40 mmHg, peak velocity ≥4.0 m/s, valve area 1.0 cm2 with increased flow) and identify patients with no flow (or contractile) reserve. However, utility in elderly patients has only been evaluated in small registries.

• Low-flow, low-gradient aortic stenosis with preserved ejection fraction (mean gradient _50%, SVi 3000, women >1600 = highly likely; men >2000, women >1200 = likely; men 50%, SVi >35 mL/m2 ). These patients usually have only moderate aortic stenosis.

• Additional diagnostic and prognostic parameters are the resting Doppler velocity index (DVI) the ratio of the left ventricular outflow tract (LVOT), time velocity integral (TVI) to that of the aortic valve jet.

Symptomatic severe aortic stenosis has dismal prognosis and early intervention is strongly recommended in all patients. Intervention is recommended in symptomatic patients with high gradient aortic stenosis, regardless of Left ventricular ejection fraction (LVEF). However, management of patients with low-gradient aortic stenosis is more challenging. LV function usually improves after intervention in patients with low-flow, low-gradient aortic stenosis, when reduced ejection fraction is predominantly caused by excessive afterload.

Management of asymptomatic severe aortic stenosis is otherwise controversial and the decision to intervene requires careful assessment of the benefits and risks in an individual patient. Intervention is recommended in asymptomatic patients with severe aortic stenosis and impaired LV function of no other cause, and those who are asymptomatic during normal activities but develop symptoms during exercise testing.

The choice between surgical and transcatheter intervention must be based upon careful evaluation of clinical, anatomical, and procedural factors by the doctors, weighing the risks and benefits of each approach for an individual patient. Surgical aortic valve replacement (SAVR) is recommended in patients with severe aortic stenosis undergoing surgical intervention on the ascending aorta or another valve. Transcatheter aortic valve implantation (TAVI) is recommended in older patients (≥75 years), or in those who are high risk (EuroSCORE IIf >8%) or unsuitable for surgery.

Authors concluded "Selection of the most appropriate mode of intervention by the Heart Team should take into account clinical characteristics (age and estimated life expectancy, general condition), anatomical characteristics, the relative risks of SAVR and TAVI, the feasibility of transfemoral TAVI, local experience and outcome data, as well as informed patient preference" are few things the doctors must consider for its management.

Reference: doi:10.1093/eurheartj/ehab395


Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News